What is BHC's P/E ratio?

Bausch Health Companies Inc (BHC) currently trades at a P/E ratio of 6.82.

Bausch Health Companies Inc reports a Return on Equity (ROE) of -208.42%.

What is BHC's dividend yield?

Bausch Health Companies Inc offers a dividend yield of 0.00%.

What is BHC's Quality Score?

Our AI rates BHC's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BHC?

Our AI Timing Score for BHC is 66 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BHC belong to?

Bausch Health Companies Inc is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange

Bausch Health Companies Inc (BHC) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

BHC AI Analysis Summary

Our AI summary for BHC: Bausch Health Companies Inc (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 6.82, ROE of -208.42%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 66/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

BHC

Bausch Health Companies Inc

USD 6.89

0.86 (14.26%) Day Change

Watchlist Portfolio Compare Chart

6.82

P/E

0.96

D/E

-208.4%

ROE

-120.2%

ROA

0.00%

Div Yield

-0.05

PEG

BAUSCH HEALTH COMPANIES INC
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 6.89 Price 0.86 (14.26%) Day Change	NEWS SCORE: 99

BHC, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	1793
Magic Formula Rank by ROE	1793
Magic Formula Rank by ROIC	669
Price	6.89
PBV / Sector	5.62 / 3.22
Earning Per Share	-3.31

PE / Sector	6.82 / 29.79 GREAT
PEG or PE/Growth / Sector	-0.05 / 0.13
Average 1M Daily Value	18.71 M GREAT
Average 1W Daily Value	51.15 M

Timing Factors

100%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

43%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-10.02 / 15.21
NPM Average (%) / Sector	-3.70 / -10.83
NPM Change Average (%) / Sector	-280.93 / 117.42
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-120.22 / 8.15
ROA Average (%) / Sector	-24.57 / 2.87
ROA Change Average (%) / Sector	-5,075.36 / 112.70
ROE (%) / Sector	-208.42 / -1.02
ROE Average (%) / Sector	-28.65 / 8.35
ROE Change Average (%) / Sector	-74.35 / 385.91
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.51
Dividend Average (%) / Sector	N/A / 3.06
Dividend Change Average (%) / Sector	N/A / 13.64

Registration Details

Analyze Date	2026-08-01 07:59:33
Symbol	BHC
Name	BAUSCH HEALTH COMPANIES INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NYSE
Listed Shares	373.48 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	2,252.06 / 10,754.62

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2150 St. Elzéar Blvd. West, Laval, QC, Canada, H7L 4A8

Phone: 514 744 6792

Website: https://www.bauschhealth.com

Employees: 20,300

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.